Upload
khalid-khalidi
View
238
Download
0
Embed Size (px)
Citation preview
8/3/2019 209-Hematology Review _ Case Studies
1/129
Hematology Review 2009
Kim Auriemma, MSN, APRN-BC, AOCN
Nurse Practitioner
Georgia Cancer Specialists
8/3/2019 209-Hematology Review _ Case Studies
2/129
Complete Blood Count
CBC or Hemogram: one of the most commonly orderedlab tests. It assesses:
White blood cells (WBC)
Red blood cells (RBC)
Platelets (PLT)
WBC Differential
8/3/2019 209-Hematology Review _ Case Studies
3/129
The Complete Blood Cell Count
TABLE 1The Complete Blood Cell CountParameter Normal adult range Indications
HemoglobinMale: 14.0 17.4 mg/dLFemale: 12.0 16.0 mg/dL
Low: AnemiaHigh: Polycythemia
HematocritMale: 42% 52%
Female: 35%
48%
Low: Anemia
High: Polycythemia
RBC countMale: 4.5 5.5 x 106/LFemale: 4.0 5.0 x 106/L
Low: AnemiaHigh: Polycythemia
WBC count 5.0 10.0 x 103/LLow: LeukopeniaHigh: Leukocytosis
Platelet count 140 400 x 103/LLow: ThrombocytopeniaHigh: Thrombocytosis
Reticulocyte count0.5% 1.5%25 85 x 103/L
Low in anemia: Low marrow outputHigh: RBC loss
RBC, red blood cell; WBC, white blood cell. Data extracted from: Fischbach FT.A Manual of Laboratory and Diagnostic Tests. Philadelphia, Pa: Lippincott Williams & Wilkins; 2003:47.
8/3/2019 209-Hematology Review _ Case Studies
4/129
Blood cells
8/3/2019 209-Hematology Review _ Case Studies
5/129
Blood
Blood makes up about 7% of a bodys weight
An average adult has 14-18 pints of blood
Four main blood types: A, O, B, AB
Rh positive or negative
Universal Donor: O-
Universal Recipient: AB +
8/3/2019 209-Hematology Review _ Case Studies
6/129
Red Blood Cells
Red blood cells transport oxygen from the lungs to theorgans and peripheral tissues, then return to thelungs carrying carbon dioxide to be exhaled. RBCsare pliable and designed to traverse the small
capillary beds. RBCs contain the oxygen carryingprotein Hemoglobin (HGB). Hematocrit measures the% of RBC mass in 100ml blood.
Normal RBC life span = 120 days
8/3/2019 209-Hematology Review _ Case Studies
7/129
Red Blood Cells
Reticulocytes: immature RBCs
Number helps to determine causes of anemia. Normalretic count is 1.0-2.0%
Low retic 2% = indicates anemia caused by RBC
loss
8/3/2019 209-Hematology Review _ Case Studies
8/129
Normal RBC
8/3/2019 209-Hematology Review _ Case Studies
9/129
Red Cell Morphology
TABLE 2Red Cell Morphology
Possible findings Significance
Burr cells Uremia, low potassium, artifact, stomach cancer, peptic ulcer disease
Spur cells Liver disease, abetalipoproteinemia
Stomatocyte Hereditary condition, alcoholic liver disease
Spherocyte Hereditary condition, immune hemolytic anemia, water dilution, posttransfusion
Schistocyte, helmetThrombotic thrombocytopenic purpura, disseminated intravascular coagulation, vasculitis,myelophthisic glomerulonephritis, prosthetic heart valve
Elliptocyte, ovalocyte Hereditary, iron deficiency, megaloblastic anemias
Teardrop cells Iron deficiency, myelophthisic, megaloblastic anemias
Sickle cells Sickle cell disease
Target cells
Postsplenectomy thalassemia, hemoglobinopathy
Parasites Malaria, babesiosis
Basophilic stippling Thalassemia, lead toxicity
Bite cells G6PD deficiency
G6PD, glucose-6-phosphate dehydrogenase.Data extracted from: Fischbach FT.A Manual of Laboratory and Diagnostic Tests. Philadelphia, Pa: Lippincott Williams & Wilkins; 2003:84-86.
8/3/2019 209-Hematology Review _ Case Studies
10/129
Anemia of Decreased Marrow
ProductionWhen the marrow slows production due to insufficient
erythropoietin (EPO), lack of other vital elements inRBC production including iron, folate, B12, or attack
on the bone marrow by a virus, toxin or cancer.
The mean corpuscular volume (MCV) is the most usefulparameter to evaluate a low retic count anemia
8/3/2019 209-Hematology Review _ Case Studies
11/129
Anemia
Microcytic anemias
have low MCV (< 80)
most common type of anemia encountered in
primary care
Differential diagnosis: Iron deficiency anemia,thalassemia, anemia of chronicdisease/inflammation, sideroblastic anemia
8/3/2019 209-Hematology Review _ Case Studies
12/129
Microcytic Anemia
TABLE 3Laboratory Findings in Microcytic Anemias
Red cell
morphology
Serum iron
level
Total iron-binding
capacityPercent saturation Serum ferritin level
Iron deficiencyanemia
Microcytic,hypochromic
Decreased Increased < 16% Decreased
Anemia ofchronic
inflammation
Normocytic,microcytic
Decreased Decreased 10% 20% Increased
Sideroblastic
anemia
Microcytic,hypochromic
Increased Normal 50% 100% Increased
ThalassemiaMicrocytic, targetcells
Normal orincreased
Normal 30% 100% Normal or increased
Data extracted from: Massey. Med Clin North Am. 19929; Adamson JW. Iron deficiency and other hypoproliferative anemias. In: Kasper DL, Braunwald E, Fauci A, et al,eds. Harrisons Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill Professional; 2004:660-666.
8/3/2019 209-Hematology Review _ Case Studies
13/129
Iron Deficiency Anemia
Definition: anemia occurs when body iron stores aredepleted by prolonged bleeding withoutreplacement. Other causes can include inadequateiron stores due to poor dietary intake and or poorabsorption or utilization
Incidence: common, seen in up to 20% of women, 50%
of pregnant women and 3% of menLab findings: anemia, low retic, low MCV and low MCHC
low ferritin, low % iron saturation, elevated TIBC,possible thrombocytosis
Signs and Symptoms: fatigue, pallor, pica, blood lossExam findings: pallor, pale conjunctiva, koilonychia,
angular stomatitis, glossitis. More severe anemiamay see tachycardia, tachypnea
8/3/2019 209-Hematology Review _ Case Studies
14/129
Iron deficiency anemia
Management:
first must identify etiology
GI bleeding
Menorrhagia Pregnancy
Poor intake
Lack of absorption
8/3/2019 209-Hematology Review _ Case Studies
15/129
8/3/2019 209-Hematology Review _ Case Studies
16/129
Iron deficiency anemia
Repletion of iron Oral Iron
Ferrous Sulfate 320mg bid-tid (most common, GIside effects)
Ferrous Gluconate 325 mg bid-tid(bettertolerated)
Niferex 150 mg qd Repliva 1 po qd (taken 21 of 28 days)
Vitamin C aids absorption of iron. Milk/calciumproducts hamper absorption
* Will need 3-6 months of oral iron to repletestores. If no response, or unable to tolerate orabsorb, refer to hematology for intravenous irontherapy (Infed, Ferrlicit, Venofur)
8/3/2019 209-Hematology Review _ Case Studies
17/129
Iron deficiency anemia
hypochromic
8/3/2019 209-Hematology Review _ Case Studies
18/129
Hemolytic anemia
Hemolytic anemia occurs when the bone marrow isunable to make up for premature destruction of redblood cells by increasing their production. Hemolysiscan be triggered by infection, medications, auto-immune responses, inherited disorders(hemoglobinopathies)
Treatment depends on cause
Folate (folic acid) is used in all hemolytic anemias tohelp stabilize the RBC membrane and decreasedestruction
8/3/2019 209-Hematology Review _ Case Studies
19/129
Hemolytic Anemia
Auto-immune hemolytic anemia - Cause is oftenunknown
Signs and Symptoms: usually very acute and seriouswith sudden rapid drop in Hgb leading to fatigue,weakness, SOB. Patient is usually hospitalized
Exam findings: pallor, tachycardia, tachypnea,
jaundice, splenomegalyLabs: low Hgb/Hct, + direct Coombs, elevated bilirubin,
elevated LDH, low serum haptoglobin, elevated reticcount
Diff Dx: anemia secondary to blood loss,hemoglobinopathy
8/3/2019 209-Hematology Review _ Case Studies
20/129
Auto-Immune Hemolytic anemia
Treatment:Steroids, usually Prednisone at high dose (1mg/kg) to
help suppress the immune system. Gradual taperover weeks to months. Splenectomy is oftenconsidered followed by other types of immune
modulation if hemolysis is not improving. Bloodtransfusions can be used to off set severe anemiahowever there is increased risk for antibodydevelopment and reactions
This can be a chronic relapsing disease
8/3/2019 209-Hematology Review _ Case Studies
21/129
Hemoglobinopathies
Hemoglobinopathy: defined as a genetic defect thatresults in an abnormal structure of one or both of theglobin chains of the hemoglobin molecule
These disorders are hereditary and some such as sickle
cell trait and G6PD deficiency once offered anevolutionary advantage over time by providingimmunity to malaria
There are hundreds of types of hemoglobinopathies andmost are not clinically apparent
8/3/2019 209-Hematology Review _ Case Studies
22/129
Thalassemia Syndromes
Definition: inherited genetic disorders that causedecreased production of normal Hgb A.
Three types:
Beta Thalassemia major
Beta Thalassemia minor
Alpha ThalassemiaIncidence: In b thalassemia can be as high as 1 in 10 in
certain Mediterranean populations. In the US approx2 million people have some form of thalassemia traitor disease. Thalassemia is the most common genetic
disorder worldwide.
8/3/2019 209-Hematology Review _ Case Studies
23/129
Thalassemia Major
Most severe form. Also known as Cooleys anemia.Lab findings: Hgb electropheresis would show increase
in Hgb A2 and F with no normal Hgb ASigns and symptoms usually present in infants prior to
6 months of age including irritability, poor feeding,pallor
Physical findings: severe anemia, jaundice andhepatosplenomegaly, as well as growth retardation
Management includes life long chronic bloodtransfusions to replace abnormal Hgb with normalHgb. Chronic transfusions lead to iron overload whichmust be removed from the body with chelation
therapy (Desferol, Exjade) to avoid liver and heartfailure.
8/3/2019 209-Hematology Review _ Case Studies
24/129
Thalassemia Minor
Definition: less severe form of thalassemia whereby ptdoes produce some normal Hgb A
Labs: Hgb electropheresis shows decreased Hgb A andincreased Hgb A2 and F. Peripheral smear oftenshows target cells and basophilic stippling. Iron
studies are normalSigns and Symptoms are usually absent
Physical exam: normal or may have splenomegaly
Management: no specific therapy is required. Ironsupplements are not recommended unless ironstudies confirm iron deficiency with low ferritin
8/3/2019 209-Hematology Review _ Case Studies
25/129
Thalassemia
Definition: Genetic disorder of the A-globin chain. 4 lociof alpha globin and severity of disease depends onnumber of alpha globin chains genetically affected.
Incidence: Most common thalassemia with highestincidence in those of Southeast Asian, Mediterranean
and African decent.Labs: Microcytic RBC, with or without anemia. May haveelevated RBC count. Hgb electropheresis may benormal
Signs and Symptoms: none to mild symptoms ofanemia including pallor, fatigue to most severe form
causing fetus with hydrops fetalis and stillbirth.
8/3/2019 209-Hematology Review _ Case Studies
26/129
Thalassemia
Physical findings: none to more severe form of disordercausing splenomegaly to most severe form in whichall 4 alpha globin chains are affected. This is notcompatible with life
Management: most often there is no specific therapy.Genetic counseling recommended for families withhistory of thalassemias prior to pregnancy
8/3/2019 209-Hematology Review _ Case Studies
27/129
RBC Target Cells
8/3/2019 209-Hematology Review _ Case Studies
28/129
Target Cells
8/3/2019 209-Hematology Review _ Case Studies
29/129
Sickle cell anemia
Sickle cell anemia genetic disorder whereby red bloodcells in a stressful environment become abnormallyshaped like a sickle and cause hemolysis, anemiaand veno-occlusion. This leads to end-organ damagein the spleen, kidneys and liver.
Incidence: More than 70,000 Americans have sickle cell
disease. About 2 million Americans, 1 in 12 AfricanAmericans - have sickle cell traitEthnic groups with sickle cell anemia are usually African
descendants although those of Mediterraneandecent can also be affected.
Labs: CBC shows anemia, adult sickle cell anemia
patients usually have elevated WBC and plateletcount, elevated retic, elevated bilirubin, Hgbelectropheresis shows abnormal Hgb SS (moresevere disease) or Hgb SC or S-beta thalassemia
8/3/2019 209-Hematology Review _ Case Studies
30/129
Sickle cell anemia
Signs and symptoms: anemia occurs as abnormalRBC have a shortened life span of only about 15 dayscompared to the usual 120 days. The RBCs are alsofragile and lack flexibility leading to veno-occlusionand resulting pain crises, as well as risk for CVA andpriapism. Sickle cell veno-occlusive crises can betriggered by infection, dehydration, temperaturechanges and other stressors to the body.
Exam findings: scleral icteris, jaundice, splenomegalyin children (adults usually have either required
splenectomy in childhood or have infarcted the spleencausing loss of spleneic function by adult age).
8/3/2019 209-Hematology Review _ Case Studies
31/129
Sickle cell disease
Normal adult spleen is11cm in craniocaudallength.
This picture illustrates a
spleen that has infarcteddue to sickle cell diseaseand shrunk to 4.5cm inlength. This spleen wouldnot be functional.
Auto-splenectomy
8/3/2019 209-Hematology Review _ Case Studies
32/129
Sickled red blood cells
8/3/2019 209-Hematology Review _ Case Studies
33/129
Pathophysiology of sickle cell disease
8/3/2019 209-Hematology Review _ Case Studies
34/129
Parasite
8/3/2019 209-Hematology Review _ Case Studies
35/129
Sickle cell anemia
Diff Dx: other hemoglobinopathies
Treatment: no cure for sickle cell disease other thanallogeneic bone marrow transplant which carriessignificant risk for morbidity and mortality.
Management of this chronic disease includesavoidance of known triggers of veno-occlusive crisis,daily folic acid. Analgesics for painful crisis patientsare often hospitalized for pain crisis for IV narcoticanalgesics, hydration with D5W (need free water),
anti-inflammatories.
8/3/2019 209-Hematology Review _ Case Studies
36/129
Sickle cell disease
Hydrea is sometimes used to treat sickle cell diseaseand decrease frequency of pain crises andhospitalizations in adult sickle cell patients. Thoughtto work by increasing fetal hgb and decreasingtendency for RBC to sickle.
Vaccination with pneumococcal vaccine q5 years inadults is recommended since spleneic function isimpaired.
Blood transfusions with exchange transfusion is used inserious cases of acute chest syndrome or priapism
and are also used in children with sickle cell diseaseas prophylaxis to reduce risk of CVA.
8/3/2019 209-Hematology Review _ Case Studies
37/129
G6PD deficiency
Glucose-6-phosphate dehydrogenase deficiency ahereditary enzyme deficiency that leads to hemolysiswhen certain drugs are ingested that induce oxidantstress on RBCs.
Incidence - Most common human enzyme deficiencyaffecting 400 million people worldwide. X-linkedrecessive disorder with more males affected thanfemales. Occurs more often in blacks
Signs and symptoms: none unless hemolysis occurscausing anemia with fatigue, SOB, dark urine
8/3/2019 209-Hematology Review _ Case Studies
38/129
G6PD deficiency
Exam findings: none specific unless having activehemolysis
Drugs to be avoided with G6PD def:
Elitec (rasburicase), Methylene blue, Pyridium,Sulfacetamide, Sulfasalazine, Isobutyl nitrite,Nitrofuratoin, Primaquine, Sulfamethoxazole(Bactrim), Toluidine blue
*G6PD deficient patient are also allergic to fava beans
8/3/2019 209-Hematology Review _ Case Studies
39/129
G6PD deficiency
Labs: show evidence of hemolysisElevated bilirubin levels
Elevated serum LDH
Low serum haptoglobin
Hemoglobinuria
Elevated retic count
Low RBC count and hemoglobin
Heinz bodies present on examination of the peripheralblood smear using special stains
Methylene blue test
Methemoglobin reduction test used for diagnosis
8/3/2019 209-Hematology Review _ Case Studies
40/129
Anemia of Chronic Disease
Definition: anemia caused by inflammatory processesoccurring due to long-standing infection, neoplasticdisease and other inflammatory disorders includingrheumatoid arthritis, SLE. These processes block irontransportation from storage sites to the bone marrowfactory. Can also be associated with renal failure anddecreased erythropoietin production
Incidence: second most common anemia behind irondeficiency anemia
Lab findings: CBC showing anemia, low or normal MCV,
normal iron studies or low % iron saturation withnormal to low TIBC, elevated CRP or sed rate,elevated BUN/creatinine
8/3/2019 209-Hematology Review _ Case Studies
41/129
Anemia of Chronic Disease
Signs and Symptoms: fatigue, pallor or asymptomatic ifpatient has long standing history of RA, SLE, otherinflammatory disease, chronic renal failure
Physical findings: none specific
Management: Treat underlying disease
If unable to determine causative factor, refer to
hematology for bone marrow biopsy
8/3/2019 209-Hematology Review _ Case Studies
42/129
Sideroblastic Anemia
Definition: anemia characterized by ringed-sideroblasts.Caused by an enzyme disorder in which the body hasadequate iron but is unable to incorporate it intohemoglobin. Iron enters the developing red blood cellwhere iron accumulates in the mitochondria giving aringed appearance to the nucleus (ie: ringedsideroblast). Can be caused by genetic defect, toxinexposure or idiopathic.
Lab findings: microcytic anemia, basophilic stipplingon peripheral smear, usually normal iron studies.Bone marrow biopsy needed if this anemia issuspected based on presentation and peripheralsmear. Check blood ETOH, lead levels
8/3/2019 209-Hematology Review _ Case Studies
43/129
Sideroblastic anemia
8/3/2019 209-Hematology Review _ Case Studies
44/129
Sideroblastic anemia
Signs and Symptoms: depend on cause. May havehistory of ETOH abuse, have altered mental status,abdominal pain or neuropathy, history of treatmentfor TB, fatigue, pallor, family history
Physical findings: pallor, abnormal neuro exam withdecreased sensory perception, tender abdomen,evidence of ETOH, enlarged spleen or liver, cardiacarrhythmia
Management: refer to hematology for management.Sometimes treated as a Myelodysplastic syndromewith epo growth factors. May progress to aplastic
anemia requiring bone marrow transplant
8/3/2019 209-Hematology Review _ Case Studies
45/129
Macrocytic Anemias
Definition: macrocytosis or megaloblastic anemia ischaracterized by anemia with elevated MCV
Incidence: fairly common, seen more in the elderly andthose with history of GI pathology or surgeries
Differential Dx:B12 deficiency, folate deficiency, historyof GI disorder or surgery, chemotherapy, chronicalcoholism, hypothyroidism, liver disease (hepatitis),splenectomy (loss of filtration through spleen leadsto larger RBCs)
8/3/2019 209-Hematology Review _ Case Studies
46/129
Macrocytic RBC
8/3/2019 209-Hematology Review _ Case Studies
47/129
B12 deficiency anemia
Definition: anemia caused by inadequate B12. Can bedue to inadequate dietary intake in vegans or morecommonly as a result of loss of intrinsic factor whichleads to inability to absorb B12 (pernicious anemia)
Lab findings: anemia on CBC, MCV elevated usually >95. Normal or low serum B12 with elevatedmethylmalonic acid, normal or elevatedhomocysteine, anti-intrinsic factor antibodies
8/3/2019 209-Hematology Review _ Case Studies
48/129
B12 deficiency
Signs and Symptoms: fatigue, pallor, neuropathy,dizziness, hair loss, memory loss/dementia inelderly, history including chronic gastritis, bariatricsurgery, auto-immune disorder.
Physical findings: pallor, tachycardia, abnormal sensory
neuro exam, tachypnea
Management:Cyanocobalamin 1000mcg IM weekly x 4 then monthly
usually for life
B12 is poorly absorbed by the oral route
8/3/2019 209-Hematology Review _ Case Studies
49/129
Folate Deficiency anemia
Definition: macrocytic anemia caused by lack of folicacid. Common in alcoholics
Lab findings: CBC with anemia, macrocytic with MCV >95. Elevated homocysteine with low or normal serumfolate
Signs and Symptoms: fatigue, pallor, unusual diet (nouncooked fruits and vegetables), alcoholism
Physical exam: none specific
Management: Folic Acid 1mg po qd
Repeat homocysteine in 3 months and if remainselevated, may increase folic acid to 2mg daily.Treatment usually long term.
8/3/2019 209-Hematology Review _ Case Studies
50/129
Increased marrow production
Elevated blood cells due toover production in themarrow. Can seeoverproduction of RBC,WBC, Platelets
8/3/2019 209-Hematology Review _ Case Studies
51/129
Erythrocytosis
Definition: Over production of red blood cells in thebone marrow.
Possible causes are:
Polycythemia Vera (PV) myeloproliferative disorderwhich leads to over production of red blood cells
(possibly also in WBC and Platelets) in the bonemarrow.
Incidence in the US: PV is relatively rare, occurring in0.6-1.6 persons per million. Occurs more in men.
Work up should be triggered for Hgb > 15 in womenand > 17 in men
8/3/2019 209-Hematology Review _ Case Studies
52/129
Polycythemia
8/3/2019 209-Hematology Review _ Case Studies
53/129
Polycythemia Vera
Lab tests would include RBC mass, serumerythropoietin levels (usually decreased), ABG, bonemarrow biopsy usually performed, JAK 2 mutationanalysis (JAK genes play important role inhematopoesis)
History and Exam findings: splenomegaly, red
complexion (plethora), fatigue, headache, dizziness,assess for clottingDiff Dx: elevated RBC from smoking, chronic cardiac or
lung disease, high altitude, dehydrationTreatment therapeutic phlebotomy 500ml weekly
until Hct < 45%, then usually maintenance
phlebotomy every 1-3 months. May requirereplacement IV fluids to avoid hypotension
8/3/2019 209-Hematology Review _ Case Studies
54/129
Secondary Erythrocytosis
Definition: elevated RBC count without other blood cellabnormality. Most common causes are smoking,dehydration and environment of chronic hypoxia
Lab findings: Elevated RBC with otherwise normal WBC,platelet count. Bone marrow biopsy would shownormal erythrocyte precursors, normal epo level
Diagnosis is often one of exclusion if polycythemia isruled out
Signs and symptoms depending on cause. May havesymptoms of chronic hypoxia, SOB, oxygenrequirement, current tobacco use. High altitude living
Management: treat underlying cause
8/3/2019 209-Hematology Review _ Case Studies
55/129
Thrombocytosis
Definition: elevated platelet count > 500,000Diff Dx includes: bone marrow myeloproliferative
disorder as in essential thrombocythemia (ET) orsecondary to iron deficiency, splenectomy, infection,malignancy or inflammatory disease
Incidence: little dataLab findings: CBC showing elevated platelet count. Iron
studies may show iron deficiency. JAK 2 mutationanalysis can be helpful
Signs and Symptoms: often asymptomatic and foundon routine CBC. ET patient may experience
headaches, TIAs
8/3/2019 209-Hematology Review _ Case Studies
56/129
Thrombocytosis
Physical findings: eval for evidence of infection,lymphadenopathy, bleeding, thrombosis
Bone marrow needed to evaluate for ET
Usually referred to hematology for work up
Management: treat underlying cause as applicable
For ET: usually no treatment unless patient issymptomatic with headaches, TIAs, thrombosis.Treatment usually consists of Anagrelide and orHydroxyurea. May consider at least ASA forasymptomatic patient with platelet count > 1 million.
8/3/2019 209-Hematology Review _ Case Studies
57/129
Platelets
8/3/2019 209-Hematology Review _ Case Studies
58/129
Thrombocytopenia
Definition: platelet count < 100,000.Differential Dx: bone marrow dysfunction, malignancy,
auto-immune response, medication, chemotherapy,acute bleeding, acute thrombosis, DIC, HIT, lab error
Incidence: ITP: 100 cases per million people per yearwith children accounting for half of those. Females
more likely to be affected.Lab/diagnostic studies: check CBC for other cytopenias,
HIT assay, platelet aggregation studies, anti-plateletantibodies, bleeding time, bone marrow biopsy wouldshow elevated megakaryocytes (platelet precursors)in destruction problem however low megakaryocytesin bone marrow production disorder. Check DICpanel. Check cultures of blood, CSF if evidence ofinfection. Radiographic studies for evidence ofDVT/PE. Spleneic ultrasound to eval for sequestration
8/3/2019 209-Hematology Review _ Case Studies
59/129
Thrombocytopenia
Signs and symptoms: bruising, bleeding, infectioussymptoms, abd pain, fever, recent history of heparin,medication use including recent chemo, thiazides,ethanol, estrogen, sulfonamides, quinine, quinidine,methyldopa, anti-epileptics
Physical findings: ecchymoses, bleeding, splenomegaly
with LUQ pain, SOB, hemoptysis (with PE), unilaterallower ext edema, + homans sign (with DVT),erythema, swelling or other evidence of infection,petechiae
Management: depending on causeFor ITP (idiopathic thrombocytopenia purpura) need to
suppress immune system since this is an auto-immune response. Usually treat with Prednisone1mg/kg qd until platelet count back to normal rangethen slowly taper. Often have relapse. Can also useIVIG, Monoclonal ab therapy with Rituxan. N-Plate
8/3/2019 209-Hematology Review _ Case Studies
60/129
Thrombocytopenia
For HIT (heparin induced thrombocytopenia) mustdiscontinue all Heparin use (considered Heparinallergic). This response causes patient to behypercoagulable despite low platelet count so patientmust be anti-coagulated with Refludan/Argatroban inhospital setting and then Warfarin as out patient for3-6 months under care of hematologist
For medication related drop discontinue offendingmedication and platelets should recover rapidly. Maybe an expected drop post chemotherapy if beingtreated for cancer
For consumption from acute thrombosis, patient needsto be anti-coagulated and platelets should recover
8/3/2019 209-Hematology Review _ Case Studies
61/129
Thrombocytopenia
Lab Error: can have platelet clumping due to EDTA tubethis may cause platelet count to appear falsely low peripheral smear examination can confirm normalplatelet count. Blood can be collected in NA citratetube and re-run to confirm normal count
For TTP (thrombotic thrombocytopenia purpura) thisrare disorder of the anticoagulation system will causepatient to require plasmapheresis to removeinhibitors of VW factor. Give pt FFP (fresh frozenplasma) to replace normal VW factor. This is a rare
but serious disease that requires care underhematologist. May see RBC schistocytes on smear
8/3/2019 209-Hematology Review _ Case Studies
62/129
Bleeding Disorders
HemophiliaDefinition: genetic disorder characterized by lack of
blood clotting factors.Hemophilia A: lack of factor VIII (most common). Sex
linked occurring in 1:10,000 malesHemophilia B: lack of factor IX (Christmas factor)
occurring in 1:100,000 malesLabs/diagnostic testing: diagnosed by checking factor
activity levels, CBC, PT/PTT, bleeding timeSigns and symptoms: easy bruising, prolonged
bleeding, painful joints due to hemarthrosis. Olderhemophiliacs likely to be infected with HIV due to
receiving contaminated factor products
8/3/2019 209-Hematology Review _ Case Studies
63/129
8/3/2019 209-Hematology Review _ Case Studies
64/129
Bleeding Disorders
Von Willebrand disease (VWD)
Definition: bleeding disorder caused by lack of VonWillebrand factor which interferes with plateletfunction thereby increasing risk for bleeding. Most
forms of VWD are mildIncidence: most common blood clotting disorderoccurring in 1 in 800-1000 people
Labs: normal CBC, bleeding time (prolonged), VonWillebrand factor assay (reduced), plateletaggregation study (reduced), Ristocetin co-factor
(reduced)
8/3/2019 209-Hematology Review _ Case Studies
65/129
Von Willebrand Disease
Signs and symptoms: easy bruising, prolonged bleedingafter surgery, dental procedure, menorrhagia,epistaxis
Physical findings: may be normal or may seeecchymoses, petechiae, bleeding
Management:Desmopressin (DDAVP) nasal spray helps to increase
factor VIII and VW factor in the bloodFresh frozen plasma/cryoprecipitate in acute bleeding
or surgery
8/3/2019 209-Hematology Review _ Case Studies
66/129
White blood cells
Definition: blood cells thatfight infection. Produced inthe bone marrow.
Elevated = leukocytosis
Decreased = leukopenia.
8/3/2019 209-Hematology Review _ Case Studies
67/129
Leukopenia
Definition: total WBC < 4,300
Differential Dx: Infection including bacterial or viral,chemotherapy, other medications (anti-epileptics,penicillins, sulfonamides, cephalosporins, thiazides,cimetidine, ethanol, immunosuppressants),
hematologic malignancy, aplastic anemia,hypersplenism, auto-immune disorders, Feltyssyndrome. Low WBC can be normal in certainpopulations
Lab studies/diagnostic testing: CBC, differential, CMP,
bone marrow biopsy
8/3/2019 209-Hematology Review _ Case Studies
68/129
Leukopenia
Signs and Symptoms: maybe none, symptoms ofinfection, fever, lymphadenopathy, weight loss, nightsweats. Check medications
Physical findings: lymphadenopathy, splenomegaly,
may be asymptomatic
Management: determine underlying cause
Blacks can have asymptomatic leukopenia as baseline
8/3/2019 209-Hematology Review _ Case Studies
69/129
Leukocytosis
Definition: WBC > 10,800
Differential Dx: Infection, Chronic inflammation,Medications (steroids), Recovery post chemotherapy,WBC growth factors (Neupogen, Leukine, Neulasta)used in cancer therapies, hematologic malignancy
(leukemia) or bone marrow dysfunction
Lab/diagnostic tests: CBC with diff, UA/cx if urinarysymptoms, CXR if resp symptoms, blood cultures,LAP (leukocyte alkaline phosphotase elevated inleukomoid reaction, decreased in leukemias)
8/3/2019 209-Hematology Review _ Case Studies
70/129
Leukocytosis
Signs and Symptoms: may be asymptomatic, fever,infectious symptoms, cough, SOB, dysuria, skininfection/abcess, rash, weight loss, fatigue, nightsweats
Physical findings: may be none. Erythema, edema, skinrash, lymphadenopathy, cachexia,
hepatosplenomegaly, abnormal heart sounds,adventitious lung sounds
Management: determine underlying cause.
If unable to determine cause or if leukocytosis persists
or is rising after treating for infection, hematologyconsult for bone marrow biopsy
8/3/2019 209-Hematology Review _ Case Studies
71/129
Leukemia
Definition: hematologic malignancy of the bone marrowwhereby abnormal immature cells crowd out normalcells. WBC can be elevated or decreased in leukemia.RBC and platelets can be normal or decreased
Types of leukemia: most common
Acute Myelogenous Leukemia
Acute Lymphocytic Leukemia
Chronic Myelogenous Leukemia
Chronic Lymphocytic Leukemia
8/3/2019 209-Hematology Review _ Case Studies
72/129
Acute Leukemia
Incidence: about 7000 cases per year in US. 80% areAML, 20% ALL
Etiology is unknown for the most part. Risk factorsinclude exposure to benzene, radiation exposure andprior treatment with cytotoxic chemotherapy
Lab findings: CBC can show elevated, normal or lowWBC count. Often see anemia at presentation as wellas thrombocytopenia. Differential often showscirculating blasts (very immature WBCs). ElevatedLDH usually seen. Bone marrow biopsy diagnostic
Signs and Symptoms: pallor, fatigue, fever, anorexia,
weight loss, weakness, palpitations, dyspnea onexertion, infection, rash, bleeding, bruising
8/3/2019 209-Hematology Review _ Case Studies
73/129
Acute Leukemia
Physical findings: Ecchymoses, bleeding, pallor,tachycardia, tachypnea, hepatosplenomegaly,petechiae, scleral hemorrhage
Management: Rapid recognition of symptoms as those
of leukemia is crucial in acute leukemia as patientscan decline rapidly and die from infectiouscomplications or hemorrhage. Referral tohematologist for work up and chemotherapy
8/3/2019 209-Hematology Review _ Case Studies
74/129
Acute Leukemia
8/3/2019 209-Hematology Review _ Case Studies
75/129
Bone Marrow Biopsy
8/3/2019 209-Hematology Review _ Case Studies
76/129
Chronic Leukemia
Definition: differs from acute leukemia in thatsymptoms have lasted more than 3 months. ForCML, the natural history of the disease usuallyincludes a chronic phase lasting 2-4 yrs. Acceleratedphase can then occur leading to progressiveleukocytosis, anemia and thrombocytopenia.Eventually a blast crisis may ensue in which thedisease may behave more like AML requiringaggressive therapy and having a poor prognosis
Incidence: 4000 cases in US per year for CML
8/3/2019 209-Hematology Review _ Case Studies
77/129
Chronic Leukemia
Lab/diagnostic testing: CBC with diff shows elevatedWBC often with basophilia. Anemia often present.Platelets may be normal or low. Usually no peripheralblasts. Marrow blasts elevated or normal. LDHincreased. With very high WBC may seehyperkalemia and hypoglycemia. Ultrasound ofspleen often done as well as CT scans to help
differentiate between leukemia and lymphoma
Signs and Symptoms: may be subtle easy fatigability,malaise, anorexia, abd discomfort and early satietyfrom enlarged spleen.
Physical findings: may be none, orhepatosplenomegaly, pallor, ecchymoses
Diagnosis made with bone marrow biopsy
8/3/2019 209-Hematology Review _ Case Studies
78/129
Chronic Leukemia
Management:CLL: many times a watch and wait approach is takenand only treated if WBC doubling time is < 6m or ptbecomes symptomatic with progressive abnormalblood counts. At that point chemotherapy would beoffered, usually IV therapy depending on pts age andperformance status
CML: Most cases of CML have a genetic 9:22translocation (termed Philadelphia Chromosome).This type of CML is treated at this time with an oraltargeted chemotherapy agent called Gleevec takendaily. There are also new agents being studied forCML that work similar to Gleevec if Gleevec fails.
8/3/2019 209-Hematology Review _ Case Studies
79/129
Lymphoma
Definition: Hematologic malignancy involvinglymphadenopathy as well as possible bone marrowand other solid organ involvement.
Types: Hodgkins Lymphoma and Non-HodgkinsLymphoma (NHL)
Incidence: About 8000 new cases of Hodgkins disease
are diagnosed each year. Usually occurring in youngadults. NHL has an incidence of up to 90,000 newcases per year
Differential Dx: infections causing lymphadenopathy,cat scratch fever, viral infections (HIV), auto-immunedisorders, endocrine disorders, sarcoidosis
Lab/diagnostic testing: CBC with diff, CMP, LDH, Beta 2microglobulin, lymph node biopsy, bone marrowbiopsy, CXR, CT scans, PET scan
8/3/2019 209-Hematology Review _ Case Studies
80/129
Lymphoma
Risk factors for development of lymphoma: EBV, HHV-8, HTLV-1 viruses have a strong association withdevelopment of lymphoid tumors. h.Pylori is a riskfactor for development of gastric MALT (mucosaassociated lymphoid tissue) lymphoma. Inherited oracquired immunodeficiency disorders also predispose
individuals to lymphoma. Increase incidence of NHLin farmers and meat workers. Increased Hodgkinsdisease in wood workers.
Signs and symptoms: Painless adenopathy, fever, nightsweats, weight loss, fatigue (B-symptoms)
Physical findings: lymphadenopathy in one or morelymph node chains, hepatosplenomegaly, pallor
8/3/2019 209-Hematology Review _ Case Studies
81/129
Lymphoma
Staging: based on number of lymph node chainsinvolved and location above and or below diaphragm,bone marrow status, extra nodal sites of disease,absence or presence of B-symptoms
Stages from IA-IVB
Histiologic subtypes also important in determiningaggressiveness of disease which guides treatmentplan offered to patient
Less aggressive NHL: follicular center cell
More aggressive NHL: diffuse large cell
8/3/2019 209-Hematology Review _ Case Studies
82/129
Lymphoma
Management:
Based on stage, and subtype for Hodgkins diseaseusually IV chemotherapy +/- radiation therapy
NHL treatment can range from watch and wait approachto very strong IV chemotherapy for the aggressivesubtypes. Bone marrow transplant is sometimesneeded if patient fails initial chemotherapy foraggressive NHL.
8/3/2019 209-Hematology Review _ Case Studies
83/129
WBC Differential
Five subtypes of WBC noted in differential include:Neutrophils (segs + bands) AKA granulocytesthese are immature WBC. Important in fightingbacterial infections. Elevated neutrophils can becaused by acute infection, chemotherapy, stressreaction, burns, tissue necrosis, chronic
inflammatory disorders. Decreased neutrophils =neutropenia. Increased risk for infection ifneutrophils < 1000. Severe risk for infection if 10,000 is CLL.Lymphopenia can be caused by acute stressful illness(MI, pneumonia) as well as steroid therapy andlymphoma
8/3/2019 209-Hematology Review _ Case Studies
84/129
WBC Differential
Monocytes increased in infection, granulomatousdisease (sarcoid), collagen vascular disease.Decreased in acute stress reaction, pt on steroids,leukemia, chemo and immunosuppressant therapies
Eosinophils Increased in allergic diseases, parasiticinfections, collagen vascular diseases, from certainmedications, leukemia. Decreased in acute stressfulillness, steroids
Basophils Increased in allergic diseases, CML, chronic
inflammatory disorders.
8/3/2019 209-Hematology Review _ Case Studies
85/129
8/3/2019 209-Hematology Review _ Case Studies
86/129
WBC differential cells
8/3/2019 209-Hematology Review _ Case Studies
87/129
Case Studies
8/3/2019 209-Hematology Review _ Case Studies
88/129
Case Study #1
History11 year old male.
Presented in emergency room with recentonset of easy bruising, bleeding gums, and
persistent epistaxis.Previously in excellent health. Mother stated
he was "never sick before in his entire life."
No history of recent viral infection, and no
family history of bleeding disorders
8/3/2019 209-Hematology Review _ Case Studies
89/129
Case Study #1CBC
(with microscopic differential)RBC 4.52 x 1012/LHGB 13.4 g/dLHCT 37.2 %MCV 82.3 fLMCH 29.6 pgMCHC 35.9 g/dL
RDW 12.1WBC 5.3 x 109/LN 44 %L 39M 14E 1B 2
PLT
8/3/2019 209-Hematology Review _ Case Studies
90/129
Case Study #1
Morphologic AlterationsResults of the blood smear exam were:RBC morphology:
Normocytic, normochromic
WBC morphology:Within normal limits(one lymphocyte shown here)
PLT morphology:
Appear increased in size
d
8/3/2019 209-Hematology Review _ Case Studies
91/129
Case Study #1
1 giant platelet seen
C S d
8/3/2019 209-Hematology Review _ Case Studies
92/129
Case Study #1
Further Laboratory StudiesBone marrow biopsy:
Aspirate:Erythrocyte and granulocyte maturation within normallimits. Megakaryocytes appear normal in number andmorphology.
Sections:Slightly hypocellular for his age, with abundantmegakaryocytes.
Coagulation:INR 0.91 (RI 0.85-1.15)PTT 24.8 sec (RI 23-34)TT
15.8 sec (RI 13-18)
C S d #1
8/3/2019 209-Hematology Review _ Case Studies
93/129
Case Study #1
Physical ExamBleeding from the left nostril. Numerous
petechiae and purpura; mostly on theextremities.
No organomegaly.
C St d #1
8/3/2019 209-Hematology Review _ Case Studies
94/129
Case Study #1
What is the most likely diagnosis?
C St d #1
8/3/2019 209-Hematology Review _ Case Studies
95/129
Case Study #1
Diagnosis
Immune thrombocytopenic purpura
(ITP)
C St d #1
8/3/2019 209-Hematology Review _ Case Studies
96/129
Case Study #1
Clinical CourseThe patient was given standard therapy for ITP for
more than a month, but failed to respond. Hisplatelet counts did not improve and he continued tohave severe nosebleeds.
Because the patient's ITP was refractory to treatment,
it was decided to perform a splenectomy. During theprocedure, he received several units of platelets, andtolerated the surgery well.
His platelet count gradually recovered; after six monthsit was 289 x 109/L.
He is followed in Hematology Clinic, and continues to dowell.
C St d #2
8/3/2019 209-Hematology Review _ Case Studies
97/129
Case Study #2
33 year old female.Immigrated to the United States from Laos
four years prior to admission. Historyobtained through an interpreter.
Multiple transfusions and splenectomy twoyears prior to admission. Reason and/ordiagnosis unclear to patient.
Presented with flu-like symptoms of fever,
malaise, epigastric discomfort andnonproductive cough.
C St d #2
8/3/2019 209-Hematology Review _ Case Studies
98/129
Case Study #2
CBC(with microscopic differential)RBC 4.15 x 10[12]/LHGB 8.1 g/dLHCT 28.6 %MCV 68.9 fLMCH 19.5 pgMCHC 28.2 g/dL
RDW 22.3WBC (corrected) 8.0 x 10[9]/LN 51 %L 36M 7E 4B 2NRBC/100 WBC 83PLT 540 x
C St d #2
8/3/2019 209-Hematology Review _ Case Studies
99/129
Case Study #2
C St d #2
8/3/2019 209-Hematology Review _ Case Studies
100/129
Case Study #2
Morphologic AlterationsResults of the blood smear exam were:RBC morphology:
3+ hypochromasia1+ polychromasia2+ anisocytosis3+ target cells
occ spherocytes and fragmentsHowell Jolly bodies present
WBC morphology:Within normal limits
PLT morphology:
Within normal limits
Case St d #2
8/3/2019 209-Hematology Review _ Case Studies
101/129
Case Study #2
Hemoglobin electrophoresis:Hemoglobin E 80 %Hemoglobin F 5 %Other hemoglobins* 15 %*Identified as hemoglobin A2, hemoglobin Barts and a hemoglobin H
mutant.Iron studies:
Serum ferritin 3234 ng/mL(RI 12-86)Serum iron 140 g/dL
(RI 65-175)TIBC 152 g/dL
(RI 250-410)Saturation 92 %
(RI 20-55)
Case Study #2
8/3/2019 209-Hematology Review _ Case Studies
102/129
Case Study #2
DiagnosisHomozygous hemoglobin E disease and alpha
thalassemia
Clinical course
The patient's flu-like symptoms subsided; they werepresumed to be viral in origin.
She was referred to the Hematology Clinic, and placedon iron chelation therapy. After 18 months, herserum ferritin had fallen to 114 ng/mL. Herhemoglobin remained in the 7 to 9 g/dL range.Chelation was discontinued, with plans to monitor
the ferritin level every six months and resumetreatment when needed.
Case Study #3
8/3/2019 209-Hematology Review _ Case Studies
103/129
Case Study #3
History39 year old female.
History of fibrocystic breast disease.
Seen for routine work-up prior tobreast biopsy.
Physical Exam
Moderate splenomegaly.
No other organomegaly.
Case Study #3
8/3/2019 209-Hematology Review _ Case Studies
104/129
Case Study #3CBC
(with microscopic differential)
RBC 4.28 x 10[12]/L
HGB 13.4 g/dL
HCT 41.2 %
MCV 96.3 fL
MCH 31.3 pg
MCHC 32.5 g/dL
WBC 133.6 x 10[9]/LN seg 56 %
N band 15
N meta 13
N myelo 4
N pro 3
L 3
M 4E 1
B 1
PLT 417 x 10[9]/L
Case Study #3
8/3/2019 209-Hematology Review _ Case Studies
105/129
Case Study #3
Case Study #3
8/3/2019 209-Hematology Review _ Case Studies
106/129
Case Study #3
Morphologic AlterationsResults of the blood smear exam were:
RBC morphology:Normocytic, normochromic
WBC morphology:Mature stages and precursors all withinnormal morphologic limits
PLT morphology:
Within normal limits
Case Study #3
8/3/2019 209-Hematology Review _ Case Studies
107/129
Case Study #3
Bone marrow biopsy:Aspirate differential (1000 cells):
Erythroblasts 9.9%
Myeloblasts 1.1N
promyelocytes 1.4N and precursors71.7L 2.0M 2.8Eand precursors 2.2B and precursors8.9 Sections:
Markedly hypercellular with increased
megakaryocytes.
Case Study #3
8/3/2019 209-Hematology Review _ Case Studies
108/129
Case Study #3
Cytochemistry:Leukocyte alkaline phosphatase[LAP]
score: 3 (RI 64-176)Cytogenetics:
46,XX,t(9;22)(q34;q11)[Philadelphiachromosome]seen in all marrow cellsanalyzed.
Case Study #3
8/3/2019 209-Hematology Review _ Case Studies
109/129
Case Study #3
Diagnosis: Chronic Myeloid Leukemia (CML)
Clinical CourseFollowing the standard preparatory regimen, the patient received an
allogeneic bone marrow transplant. The donor was her HLA-matched brother.
Her post-transplant course went well, and 28 days later, herhemoglobin was 11.9 g/dL, WBC 2.0 x 10[9]/L, and PLT 84 x
10[9]/L. Her marrow showed evidence of good engraftment in allthree cell lines.Cytogenetics showed 46,XY normal karyotype in all marrow cells
analyzed. No 46,XX cells and no cells with a Philadelphiachromosome were seen.
This patient continues to be followed in Hematology Clinic. At her lastvisit, ten years post-transplant, she was still doing well and hadno evidence of recurrent disease. Molecular diagnostic studiesperformed at that time were negative for BCR-abl transcripts.
Case Study #4
8/3/2019 209-Hematology Review _ Case Studies
110/129
Case Study #4
18 year old male student from Nigeria.Came to the emergency room with symptoms
of fever, shaking chills, nausea, andgeneralized malaise; occurring
intermittently over the past five days.Physical Exam
Fever of 103.3F.Tachycardia with a heart rate of 122.
Otherwise within normal limits
Case Study #4
8/3/2019 209-Hematology Review _ Case Studies
111/129
Case Study #4
CBC(with microscopic differential)
RBC 5.85 x 10[12]/L
HGB 13.3 g/dL
HCT 41.8 %
MCV 71.5 fL
MCH 22.7 pg
MCHC 31.8 g/dL
RDW 12.1
WBC 6.2 x 10[9]/L
N 89 %
L 8
M 2
E 1
B 0
PLT 102 x 10
Case Study #4
8/3/2019 209-Hematology Review _ Case Studies
112/129
Case Study #4
Case Study #4
8/3/2019 209-Hematology Review _ Case Studies
113/129
Case Study #4
Morphologic AlterationsResults of the blood smear exam were:
RBC morphology:NormochromicNumerous red cells contain intraerythrocyticorganisms. Infected RBCs are enlarged; some are
oval shaped, others appear somewhat "fimbriated."Doubly infected cells are present, and severalmorphologic stages can be found, including ringforms, mature schizonts, and gametocytes.
WBC morphology:
Within normal limits(one lymphocyte shown here)
Case Study #4
8/3/2019 209-Hematology Review _ Case Studies
114/129
Case Study #4
PLT morphology:normal
RBC enzyme: G6PD 11.7 U/g Hgb
(RI 4.6-13.5)
Case Study #4
8/3/2019 209-Hematology Review _ Case Studies
115/129
Case Study #4
Diagnosis - MalariaUpon further questioning, the patient stated that he hadarrived in the United States from Nigeriaapproximately six months prior to this visit. Shortlyafter his arrival, he had experienced a similar illnessthat was diagnosed as malaria. Medication was
prescribed, but once he felt better he did notcontinue to take it.
Based on the blood smear morphology, the periodicpattern of his fever and chills, and his travel history,the causative organism was identified as Plasmodiumovale.
Case Study #4
8/3/2019 209-Hematology Review _ Case Studies
116/129
Case Study #4
Clinical CourseThe patient was hydrated with normal saline, andstarted on appropriate treatment for the erythrocyticstages of malaria. Several days later he began asecond course of therapy to eliminate theexoerythrocytic (hepatic) forms of the organism. He
completed the course of therapy, and on subsequentvisits was asymptomatic.
Note: On the basis of his low MCV, his relatively highRBC count, and his ethnic background, it is likelythat this patient also has alpha thalassemia trait.
Case Study #5
8/3/2019 209-Hematology Review _ Case Studies
117/129
Case Study #5
History:70 year old female.Symptoms of dyspnea on exertion, easy
fatigability, and lassitude for past 2 to 3months.
Denied hemoptysis, GI, or vaginal bleeding.Claimed diet was good, but appetite varied.Physical Exam:Other than pallor, no significant physical
findings were noted. Occult blood was
negative.
Case Study #5
8/3/2019 209-Hematology Review _ Case Studies
118/129
Case Study #5
CBC(with microscopic differential)
RBC 3.71 x 10[12]/L
HGB 5.9 g/dL
HCT 20.9 %
MCV 56.2 fL
MCH 15.9 pg
MCHC 28.3 g/dL
RDW 20.2
WBC 5.9 x 10[9]/L
N 82 %
L 13
M 1
E 4
B 0
PLT 383 x 10[9]/
Case Study #5
8/3/2019 209-Hematology Review _ Case Studies
119/129
Case Study #5
Case Study #5
8/3/2019 209-Hematology Review _ Case Studies
120/129
Case Study #5
Morphologic Alterations
Results of the blood smear exam were:
RBC morphology:2+ hypochromasia3+ microcytosis2+ anisocytosis
2+ elliptocytes and target cellsocc teardrops and fragments
WBC morphology:Within normal limits(one lymphocyte shown here)
PLT morphology:Within normal limits
Case Study #5
8/3/2019 209-Hematology Review _ Case Studies
121/129
Case Study #5
Iron studies were performed, and resultswere:
serum ferritin
8/3/2019 209-Hematology Review _ Case Studies
122/129
Case Study #5
DiagnosisIron deficiency anemiaClinical CourseDiagnostic procedures included upper GI endoscopy,
colonoscopy, and small bowel biopsy. All werenegative.
The patient received packed RBC transfusions and wasstarted on iron therapy.She refused any further laboratory testing or other
procedures, and was discharged at her own request.She was lost to follow-up.
The etiology of her iron deficiency anemia could not be
determined, but it was most likely nutritional.
Case Study #6
8/3/2019 209-Hematology Review _ Case Studies
123/129
Case Study #6
History75 year old male.
Symptoms of severe headache andgeneralized pruritis.
Physical ExamSpleen palpable 10 cm. below left
costal margin. Liver palpable 3 cm.below right costal margin. The rest ofthe exam was within normal limits.
Case Study #6
8/3/2019 209-Hematology Review _ Case Studies
124/129
Case Study #6
CBC(with microscopic differential)
RBC 7.70 x 10[12]/L
HGB 17.3 g/dL
HCT 54.3 %
MCV 97.1 fL
MCH 32.2 pg
MCHC 33.2 g/dL
RDW 16.4
WBC 18.3 x 10[9]/L
N seg 79 %
N myelocyte 5 %
L 9
M 4E 0
B 3
PLT 484 x 10
Case Study #6
8/3/2019 209-Hematology Review _ Case Studies
125/129
Case Study #6
Case Study #6
8/3/2019 209-Hematology Review _ Case Studies
126/129
Case Study #6
Morphologic AlterationsResults of the blood smear exam were:
RBC morphology:Essentially normocytic, normochromic
WBC morphology:Within normal limits
PLT morphology:Within normal limits
Case Study #6
8/3/2019 209-Hematology Review _ Case Studies
127/129
Case Study #6
Further Laboratory StudiesBone marrow biopsy:Aspirate differential:
Within normal limitsSections:
Markedly hypercellular for age.Cytogenetics:46,XY. No numerical or structural
chromosome abnormalities detected.Pulmonary function:
Oxygen saturation: 97% (RI 94-100)
Case Study #6
8/3/2019 209-Hematology Review _ Case Studies
128/129
Case Study #6
DiagnosisPolycythemia vera
Clinical Course
The patient is being followed by hislocal physician, and treated withperiodic phlebotomy.
8/3/2019 209-Hematology Review _ Case Studies
129/129
Thank You!
www.gacancer.com
E-mail me at:
http://www.gacancer.com/http://www.gacancer.com/